ESC Premium Access

Vasodilating betablockers for our patients. Why to prefer them?

Event: ESC CONGRESS 2016
Topic: Pharmacologic therapy
Session type: Satellite Symposium
Sponsored by MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.
Date: 29 August 2016
Time: 13:00 - 13:45

Session

2 presentations in this session

From the selectivity to the clinical and pharmacoeconomic outcomes.

Speaker: Professor F. Messerli (New York, US)
Thumbnail

Betablockers in fixed dose combinations: what’s new?

Speaker: Professor G. Mancia (Milan, IT)
Thumbnail

2 speakers from this session

Professor Franz Messerli

Mount Sinai Medical Center, New York (United States of America)
7 presentations
0 follower

Professor Giuseppe Mancia

University of Milan Bicocca, Milan (Italy)
21 presentations
0 follower

This platform is supported by

logo Novo Nordisk